Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Isomerase Therapeutics Limited
Isomerase Therapeutics Limited is an active company incorporated on 18 December 2012 with the registered office located in Saffron Walden, Essex. Isomerase Therapeutics Limited was registered 12 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
08335008
Private limited company
Age
12 years
Incorporated
18 December 2012
Size
Small
Balance sheet is under
£7.5M
Under
50 employees
Confirmation
Due Soon
Dated
31 October 2024
(1 year ago)
Next confirmation dated
31 October 2025
Due by
14 November 2025
(11 days remaining)
Last change occurred
12 months ago
Accounts
Submitted
For period
1 Jan
⟶
31 Dec 2024
(1 year)
Accounts type is
Small
Next accounts for period
31 December 2025
Due by
30 September 2026
(11 months remaining)
Learn more about Isomerase Therapeutics Limited
Contact
Update Details
Address
First Floor Newnham Building
Chesterford Research Park, Little Chesterford
Cambridge
CB10 1XL
United Kingdom
Same address for the past
5 years
Companies in CB10 1XL
Telephone
01223911856
Email
Available in Endole App
Website
Isomerase.co.uk
See All Contacts
People
Officers
4
Shareholders
26
Controllers (PSC)
1
Matthew Alan Gregory
Director • Ceo & Cso • British • Lives in England • Born in Jul 1975
Robert Alec Booth
Director • Non-Executive Director • British • Lives in England • Born in Jun 1952
Professor Barrie Wilkinson
Director • Non-Executive Director • British • Lives in UK • Born in Jul 1969
Dr Steven James Moss
Director • Cto • British • Lives in England • Born in Apr 1974
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
John Innes Enterprises Limited
Professor Barrie Wilkinson is a mutual person.
Active
Linaro Group Limited
Robert Alec Booth is a mutual person.
Active
Cfo-Plus Limited
Robert Alec Booth is a mutual person.
Dissolved
Spiral Bio Limited
Dr Steven James Moss is a mutual person.
Dissolved
Bioengine Limited
Dr Steven James Moss is a mutual person.
Dissolved
Biotide Limited
Dr Steven James Moss is a mutual person.
Dissolved
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period
31 Dec
⟶
31 Dec 2024
Traded for
12 months
Cash in Bank
£1.39M
Decreased by £349.59K (-20%)
Turnover
Unreported
Same as previous period
Employees
37
Same as previous period
Total Assets
£3.4M
Increased by £84.3K (+3%)
Total Liabilities
-£484.58K
Decreased by £2.32K (-0%)
Net Assets
£2.91M
Increased by £86.62K (+3%)
Debt Ratio (%)
14%
Decreased by 0.43% (-3%)
See 10 Year Full Financials
Latest Activity
Small Accounts Submitted
5 Months Ago on 14 May 2025
Matthew Alan Gregory Details Changed
7 Months Ago on 27 Mar 2025
Notification of PSC Statement
7 Months Ago on 11 Mar 2025
Matthew Alan Gregory (PSC) Resigned
8 Months Ago on 5 Mar 2025
Steven James Moss (PSC) Resigned
8 Months Ago on 5 Mar 2025
Confirmation Submitted
12 Months Ago on 7 Nov 2024
Small Accounts Submitted
1 Year 1 Month Ago on 16 Sep 2024
Simon Eric Aspland Resigned
1 Year 6 Months Ago on 22 Apr 2024
Confirmation Submitted
1 Year 11 Months Ago on 17 Nov 2023
Dr Simon Eric Aspland Appointed
2 Years Ago on 2 Nov 2023
Get Alerts
Get Credit Report
Discover Isomerase Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Accounts for a small company made up to 31 December 2024
Submitted on 14 May 2025
Director's details changed for Matthew Alan Gregory on 27 March 2025
Submitted on 31 Mar 2025
Statement of capital following an allotment of shares on 27 March 2025
Submitted on 31 Mar 2025
Cessation of Matthew Alan Gregory as a person with significant control on 5 March 2025
Submitted on 11 Mar 2025
Notification of a person with significant control statement
Submitted on 11 Mar 2025
Cessation of Steven James Moss as a person with significant control on 5 March 2025
Submitted on 11 Mar 2025
Statement of capital following an allotment of shares on 5 January 2025
Submitted on 13 Feb 2025
Confirmation statement made on 31 October 2024 with updates
Submitted on 7 Nov 2024
Statement of capital following an allotment of shares on 1 October 2024
Submitted on 2 Oct 2024
Accounts for a small company made up to 31 December 2023
Submitted on 16 Sep 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs